Old Web
English
Sign In
Acemap
>
Paper
>
Switch maintenance therapy with racotumomab or nimotuzumab vs docetaxel for NSCLC patients
Switch maintenance therapy with racotumomab or nimotuzumab vs docetaxel for NSCLC patients
2016
M. Hernández
Elia Neninger
Ramon Alberto Ortiz
K. Camacho
Rosa M. Amador
L. Bello
Y. Flores
Soraida Acosta
G. Pichs
M. Cała
M. Corella
Y. Jiménez
Y Díaz
Carmen Viada
M. Robina
Anet Valdes
Ivis Mendoza
Pedro Pablo Guerra
Amparo Macías
Tania Crombet
Keywords:
Racotumomab
General surgery
Nimotuzumab
Cancer research
Maintenance therapy
Medicine
Docetaxel
Oncology
Internal medicine
Correction
Source
Cite
Save
Machine Reading By IdeaReader
0
References
0
Citations
NaN
KQI
[]